ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.07
+0.36 (7.64%)
At close: Nov 20, 2024, 4:00 PM
4.860
-0.210 (-4.14%)
After-hours: Nov 20, 2024, 6:22 PM EST
ENDRA Life Sciences Stock Forecast
NDRA's stock price has decreased by -99.71% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ENDRA Life Sciences stock has a target of 14,000, which predicts an increase of 276,034.12% from the current stock price of 5.07.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for NDRA is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $17,500 → $14,000 | Strong Buy | Maintains | $17,500 → $14,000 | +276,034.12% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $175,000 → $15,750 | Strong Buy | Reiterates | $175,000 → $15,750 | +310,550.89% | Mar 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $210,000 → $175,000 | Strong Buy | Maintains | $210,000 → $175,000 | +3,451,576.53% | Apr 7, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $210,000 | Strong Buy | Initiates | $210,000 | +4,141,911.83% | Jul 15, 2019 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
306.00K
EPS This Year
-395.56
EPS Next Year
-318.09
from -395.56
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | n/a | 315,000 |
| Avg | n/a | 306,000 |
| Low | n/a | 294,000 |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -407.19 | -327.44 |
| Avg | -395.56 | -318.09 |
| Low | -380.04 | -305.61 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.